Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venexia M Walker

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
BMJ Open|December 15, 2016
Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research DatalinkVenexia M Walker, Neil M Davies, Tim Jones, et al.
JAMA Network Open|August 27, 2024
Genetic Insights Into Perinatal Outcomes of Maternal Antihypertensive Therapy During PregnancyCiarrah-Jane S Barry, Venexia M Walker, Christy Burden, et al.
International Journal of Epidemiology|November 25, 2022
How to estimate heritability: a guide for genetic epidemiologistsCiarrah-Jane S Barry, Venexia M Walker, Rosa Cheesman, et al.
Wellcome Open Research|November 20, 2019
Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypesVenexia M Walker, Neil M Davies, Gibran Hemani, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2021
Genetically Predicted Blood Pressure and Risk of Atrial FibrillationMatthew C Hyman, Michael G Levin, Dipender Gill, et al.
Plos Genetics|February 23, 2023
Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progressionRuth E Mitchell, April E Hartley, Venexia M Walker, et al.
Diabetologia|February 7, 2022
Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetesVenexia M Walker, Marijana Vujkovic, Alice R Carter, et al.
Ebiomedicine|May 2, 2022
Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid managementNikhil K Khankari, Jacob M Keaton, Venexia M Walker, et al.
Ebiomedicine|July 3, 2023
A genetically supported drug repurposing pipeline for diabetes treatment using electronic health recordsMegan M Shuey, Kyung Min Lee, Jacob Keaton, et al.
Circulation|June 18, 2021
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery DiseaseMichael G Levin, Verena Zuber, Venexia M Walker, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BMJ Open|December 15, 2016
Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research DatalinkVenexia M Walker, Neil M Davies, Tim Jones, et al.
JAMA Network Open|August 27, 2024
Genetic Insights Into Perinatal Outcomes of Maternal Antihypertensive Therapy During PregnancyCiarrah-Jane S Barry, Venexia M Walker, Christy Burden, et al.
International Journal of Epidemiology|November 25, 2022
How to estimate heritability: a guide for genetic epidemiologistsCiarrah-Jane S Barry, Venexia M Walker, Rosa Cheesman, et al.
Wellcome Open Research|November 20, 2019
Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypesVenexia M Walker, Neil M Davies, Gibran Hemani, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2021
Genetically Predicted Blood Pressure and Risk of Atrial FibrillationMatthew C Hyman, Michael G Levin, Dipender Gill, et al.
Plos Genetics|February 23, 2023
Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progressionRuth E Mitchell, April E Hartley, Venexia M Walker, et al.
Diabetologia|February 7, 2022
Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetesVenexia M Walker, Marijana Vujkovic, Alice R Carter, et al.
Ebiomedicine|May 2, 2022
Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid managementNikhil K Khankari, Jacob M Keaton, Venexia M Walker, et al.
Ebiomedicine|July 3, 2023
A genetically supported drug repurposing pipeline for diabetes treatment using electronic health recordsMegan M Shuey, Kyung Min Lee, Jacob Keaton, et al.
Circulation|June 18, 2021
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery DiseaseMichael G Levin, Verena Zuber, Venexia M Walker, et al.
Pageof 3